Michael J. McElhaugh

ABUS

Michael J. McElhaugh serves as Interim President & CEO at Arbutus Biopharma Corporation (ABUS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$101.6K

Net Position

Net Seller

$101.6K

Companies Traded

ABUS

Active Period

Feb 2024 – Feb 2025

2 total trades

Most Recent

Sell ABUS

Feb 4, 2025 · $78.1K

Michael J. McElhaugh's Insider Trading at Arbutus Biopharma Corporation (ABUS)

Buys

0 · $0.00

Sells

2 · $101.6K

Total Shares Bought

Total Shares Sold

33,954

ABUS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 4, 2025	Sell	23,790	$3.28	$78.1K	0
Feb 1, 2024	Sell	10,164	$2.31	$23.5K	0

Explore More Insider Trading Data

ABUS Insider Trading Activity

View all insider trades at Arbutus Biopharma Corporation

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity